Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis

Toxins

Volumn 5, Issue 6, 2013, Pages 1180-1201

  Vinante, Fabrizio ^a   Rigo, Antonella ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

EGFR ErbB HER; GPCR; HB EGF; Hematopoiesis; Leukemia; Myeloma

Indexed keywords

DIPHTHERIA TOXIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; RECEPTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

CELL PROLIFERATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MULTIPLE MYELOMA; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

CHEMOKINE CXCL12; HEMATOPOIESIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS;

EID: 84880970570     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5061180     Document Type: Review

References (156)

1. Higashiyama, S.; Abraham, J.A.; Miller, J.; Fiddes, J.C.; Klagsbrun, M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251, 936-939.
2. Higashiyama, S.; Lau, K.; Besner, G.E.; Abraham, J.A.; Klagsbrun, M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 1992, 267, 6205-6212.
3. Naglich, J.G.; Metherall, J.E.; Russel, D.W.; Eidels, L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992, 69, 1051-1061.
4. Iwamoto, R.; Higashiyama, S.; Mitamura, T.; Taniguchi, N.; Klagsbrun, M.; Mekada, E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994, 13, 2322-2330.
5. Mitamura, T.; Higashiyama, S.; Taniguchi, N.; Klagsbrun, M.; Mekada, E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 1995, 270, 1015-1019.
6. Chang, M.P.; Bramhall, J.; Graves, S.; Bonavida, B.; Wisnieski, B.J. Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition. J. Biol. Chem. 1989, 264, 15261-15267.
7. Blotnick, S.; Peoples, G.E.; Freeman, M.R.; Eberlein, T.J.; Klagsbrun, M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 1994, 91, 2890-2894.
8. Peoples, G.E.; Blotnick, S.; Takahashi, K.; Freeman, M.R.; Klagsbrun, M.; Eberlein, T.J. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl. Acad. Sci. USA 1995, 92, 6547-6551.
9. Vinante, F.; Marchi, M.; Rigo, A.; Scapini, P.; Pizzolo, G.; Cassatella, M.A. Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils. Blood 1999, 94, 3169-3177.
10. Powell, P.P.; Klagsbrun, M.; Abraham, J.A.; Jones, R.C. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 1993, 143, 784-793.
11. Vinante, F.; Rigo, A.; Papini, E.; Cassatella, M.A.; Pizzolo, G. Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor expression by acute myeloid leukemia cells. Blood 1999, 93, 1715-1723.
12. De Vos, J.; Couderc, G.; Tarte, K.; Jourdan, M.; Requirand, G.; Delteil, M.C.; Rossi, J.F.; Mechti, N.; Klein, B. Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood 2001, 98, 771-780.
13. Dluz, S.; Higashiyama, S.; Damm, D.; Abraham, J.A.; Klagsbrun, M. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 1993, 268, 18330-18334.
14. Yoshizumi, M.; Kourembanas, S.; Temizer, D.H.; Cambria, R.P.; Quertermous, T.; Lee, M.E. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 1992, 267, 9467-9469.
15. Hashimoto, K.; Higashiyama, S.; Asada, H.; Hashimura, E.; Kobayashi, T.; Sudo, K.; Nakagawa, T.; Damm, D.; Yoshikawa, K.; Taniguchi, N. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 1994, 269, 20060-20066.
16. Mishima, K.; Higashiyama, S.; Asai, A.; Yamaoka, K.; Nagashima, Y.; Taniguchi, N.; Kitanaka, C.; Kirino, T.; Kuchino, Y. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol. 1998, 96, 322-328.
17. Raab, G.; Klagsbrun, M. Heparin-binding EGF-like growth factor. Biochem. Biophys. Acta 1997, 1333, 179-199.
18. Rigo, A.; Gottardi, M.; Zamò, A.; Mauri, P.; Bonifacio, M.; Krampera, M.; Damiani, E.; Pizzolo, G.; Vinante, F. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol. Cancer 2010, 9, 273.
19. Elenius, K.; Paul, S.; Allison, G.; Sun, J.; Klagsbrun, M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997, 16, 1268-1278.
20. Nakamura, K.; Iwamoto, R.; Mekada, E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin a3p1 at cell-cell contact sites. J. Cell Biol 1995, 129, 1691-1705.
21. Iwamoto, R.; Handa, K.; Mekada, E. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor. J. Biol Chem. 1999, 274, 25906-25912.
22. Takemura, T.; Kondo, S.; Homma, T.; Sakai, M.; Harris, R.C. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells. J. Biol Chem. 1997, 272, 31036-31042.
23. Miyoshi, E.; Higashiyama, S.; Nakagawa, T.; Hayashi, N.; Taniguchi, N. Membrane-anchored heparin-binding EGF-like growth factor acts as a tumor survival factor in hepatoma cell line. J. Biol Chem. 1997, 272, 14349-14355.
24. Higashiyama, S. Metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor and its pathophysiological roles. Protein. Pept. Lett. 2004, 11, 443-450.
25. Izumi, Y.; Hirata, M.; Hasuwa, H.; Iwamoto, R.; Umata, T.; Miyado, K.; Tamai, Y.; Kurisaki, T.; Sehara-Fujisawa, A.; Ohno, S.; Mekada, E. A metalloprotease-disintegrin, MDC9/meltrin-y/ADAM9 and PKC6 are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998, 17, 7260-7272.
26. Lemjabbar, H.; Basbaum, C. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 2002, 8, 41-46.
27. Asakura, M.; Kitakaze, M.; Takashima, S.; Liao, Y.; Ishikura, F.; Yoshinaka, T.; Ohmoto, H.; Node, K.; Yoshino, K.; Ishiguro, H.; Asanuma, H.; Sanada, S.; Matsumura, Y.; Takeda, H.; Beppu, S.; Tada, M.; Hori, M.; Higashiyama, S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8, 35-40.
28. Sunnarborg, S.W.; Hinkle, C.L.; Stevenson, M.; Russell, W.E.; Raska, C.S.; Peschon, J.J.; Castner, B.J.; Gerhart, M.J.; Paxton, R.J.; Black, R.A.; Lee, D.C. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol Chem. 2002, 277, 12838-12845.
29. Yan, Y.; Shirakabe, K.; Werb, Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol 2002, 158, 221-226.
30. Abramovitch, R.; Neeman, M.; Reich, R.; Stein, I.; Keshet, E.; Abraham, J.A.; Solomon, A.; Marikovsky, M. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett. 1998, 425, 441-447.
31. Higashiyama, S.; Abraham, J.A.; Klagsbrun, M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol 1993, 122, 933-940.
32. Faber-Elman, A.; Solomon, A.; Abraham, J.A.; Marikovsky, M.; Schwartz, M. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: In vitro simulation. J. Clin. Invest. 1996, 97, 162-171.
33. Hieda, M.; Isokane, M.; Koizumi, M.; Higashi, C.; Tachibana, T.; Shudou, M.; Taguchi, T.; Hieda, Y.; Higashiyama, S. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane. J. Cell Biol. 2008, 180, 763-769.
34. Nanba, D.; Mammoto, A.; Hashimoto, K.; Higashiyama, S. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J. Cell Biol. 2003, 163, 489-502.
35. Nakano, T.; Raines, E.W.; Abraham, J.A.; Klagsbrun, M.; Ross, R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc. Natl. Acad. Sci. USA 1994, 91, 1069-1073.
36. Marikovsky, M.; Breuing, K.; Liu, P.Y.; Eriksson, E.; Higashiyama, S.; Farber, P.; Abraham, J.; Klagsbrun, M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. USA 1993, 90, 3889-3893.
37. Zhang, Z.; Funk, C.; Glasser, S.R.; Mulholland, J. Progesterone regulation of heparin-binding epidermal growth factor-like growth factor gene expression during sensitization and decidualization in the rat uterus: Effects of the antiprogestin, ZK 98.299. Endocrinology 1994, 135, 1256-1263.
38. Freeman, M.R.; Yoo, J.J.; Raab, G.; Soker, S.; Adam, R.M.; Schneck, F.X.; Renshaw, A.A.; Klagsbrun, M.; Atala, A. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J. Clin. Invest. 1997, 99, 1028-1036.
39. Freeman, M.R.; Paul, S.; Kaefer, M.; Ishikawa, M.; Adam, R.M.; Renshaw, A.A.; Elenius, K.; Klagsbrun, M. Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. J. Cell. Biochem. 1998, 68, 328-338.
40. Arbiser, J.L.; Raab, G.; Rohan, R.M.; Paul, S.; Hirschi, K.; Flynn, E.; Price, E.R.; Fisher, D.E.; Cohen, C.; Klagsbrun, M. Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am. J. Pathol. 1999, 155, 723-729.
41. Mehta, V.B.; Besner, G.E. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors 2007, 25, 253-263.
42. Nishi, E.; Prat, A.; Hospital, V.; Elenius, K.; Klagsbrun, M. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J. 2001, 20, 3342-3350.
43. Plowman, G.D.; Culouscou, J.M.; Whitney, G.S.; Green, J.M.; Carlton, G.W.; Foy, L.; Neubauer, M.G.; Shoyab, M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 1993, 90, 1746-1750.
44. Elenius, K.; Corfas, G.; Paul, S.; Choi, C.J.; Rio, C.; Plowman, G.D.; Klagsbrun, M. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J. Biol. Chem. 1997, 272, 26761-26768.
45. Krampera, M.; Pasini, A.; Rigo, A.; Scupoli, M.T.; Tecchio, C.; Malpeli, G.; Scarpa, A.; Dazzi, F.; Pizzolo, G.; Vinante, F. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 2005, 106, 59-66.
46. Lue, H-W.; Yang, X.; Wang, R.; Qian, W.; Xu, R.Z.H.; Lyles, R.; Osunkoya, A.O.; Zhou, B.P.; Vessella, R.L.; Zayzafoon, M.; Liu, Z-R.; Zhau, H.E.; Chung, L.W.K. LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling. PLoS One 2011, 6, e27720.
47. Umeda, Y.; Miyazaki, Y.; Shiinoki, H.; Higashiyama, S.; Nakanishi, Y.; Hieda, Y. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev. Biol. 2001, 237, 202-211.
48. Chen, X.; Raab, G.; Deutsch, U.; Zhang, J.; Ezzell, R.M.; Klagsbrun, M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J. Biol. Chem. 1995, 270, 18285-18294.
49. Oyagi, A.; Oida, Y.; Kakefuda, K.; Shimazawa, M.; Shioda, N.; Moriguchi, S.; Kitaichi, K.; Nanba, D.; Yamaguchi, K.; Furuta, Y.; Fukunaga, K.; Higashiyama, S.; Hara, H. Generation and characterization of conditional heparin-binding EGF-Like growth factor knockout mice. PLoS One 2009, 4, e7461.
50. Iwamoto, R.; Mekada, E. ErbB and HB-EGF signaling in heart development and function. Cell Struct. Funct. 2006, 31, 1-14.
51. Kaneto, H.; Miyagawa, J.; Kajimoto, Y.; Yamamoto, K.; Watada, H.; Umayahara, Y.; Hanafusa, T.; Matsuzawa, Y.; Yamasaki, Y.; Higashiyama, S.; Taniguchi, N. Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. A potential role of PDX-1 in transcriptional activation. J. Biol. Chem. 1997, 272, 29137-29143.
52. Riese, D.J., 2nd; Stern, D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998, 20, 41-48.
53. Yarden, Y.; Sliwkowski, M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
54. Schlessinger, J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004, 306, 1506-1507.
55. Paria, B.C.; Elenius, K.; Klagsbrun, M.; Dey, S.K. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. Development 1999, 126, 1997-2005.
56. Iwamoto, R.; Yamazaki, S.; Asakura, M.; Takashima, S.; Hasuwa, H.; Miyado, K.; Adachi, S.; Kitakaze, M.; Hashimoto, K.; Raab, G.; Nanba, D.; Higashiyama, S.; Hori, M.; Klagsbrun, M.; Mekada, E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 2003, 100, 3221-3226.
57. Shishido, Y.; Sharma, K.D.; Higashiyama, S.; Klagsbrun, M.; Mekada, E. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 1995, 270, 29578-29585.
58. Iwamoto, R.; Mekada, E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 2000, 11, 335-344.
59. Hieda, M.; Koizumi, M.; Higashi, C.; Tachibana, T.; Taguchi, T.; Higashiyama, S. The cytoplasmic tail of heparin-binding EGF-like growth factor regulates bidirectional intracellular trafficking between the plasma membrane and ER. FEBS Open Bio. 2012, 2, 339-344.
60. Kinugasa, Y.; Hieda, M.; Hori, M.; Higashiyama, S. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression. J. Biol. Chem. 2007, 282, 14797-14806.
61. Wang, X.; Mizushima, H.; Adachi, S.; Ohishi, M.; Iwamoto, R.; Makada, E. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor. Cell. Struct. Funct. 2006, 31, 15-27.
62. Hynes, N.E.; Lane, H.A. ErbB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5, 341-354.
63. Kunami, N.; Yotsumoto, F.; Ishitsuka, K.; Fukami, T.; Odawara, T.; Manabe, S.; Ishikawa, T.; Tamura, K.; Kuroki, M.; Miyamoto, S. Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia. Anticancer Res. 2011, 31, 2483-2488.
64. Miyamoto, S.; Yagi, H.; Yotsumoto, F.; Kawarabayashi, T.; Mekada, E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci. 2006, 97, 341-347
65. Yotsumoto, F.; Yagi, H.; Suzuki, S.O.; Oki, E.; Tsujioka, H.; Hachisuga, T.; Sonoda, K.; Kawarabayashi, T.; Mekada, E.; Miyamoto, S. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem. Biophys. Res. Commun. 2008, 365, 555-561.
66. Hackel, P.O.; Zwick, E.; Prenzel, N.; Ullrich, A. Epidermal growth factors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 1999, 11, 184-189
67. Rigo, A.; Gottardi, M.; Damiani, E.; Bonifacio, M.; Ferrarini, I.; Mauri, P.; Vinante, F. CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurin. PLoS One 2012, 7, e34432.
68. Saito, T.; Okada, S.; Ohshima, K.; Yamada, E.; Sato, M.; Uehara, Y.; Shimizu, H.; Pessin, J.E.; Mori, M. Differential Activation of Epidermal Growth Factor (EGF) Receptor Downstream Signaling Pathways by Betacellulin and EGF. Endocrinology 2004, 145, 4232-4243.
69. Sahin, U.; Weskamp, G.; Kelly, K.; Zhou, H.M.; Higashiyama, S.; Peschon, J.; Hartmann, D.; Saftig, P.; Blobel, C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 2004, 164, 769-779.
70. Dethlefsen, S.M.; Raab, G.; Moses, M.A.; Adam, R.M.; Klagsbrun, M.; Freeman, M.R. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J. Cell. Biochem. 1998, 69, 143-153.
71. Prenzel, N.; Zwick, E.; Daub, H.; Leserer, M.; Abraham, R.; Wallasch, C.; Ullrich, A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402, 884-888.
72. Daub, H.; Wallasch, C.; Lankenau, A.; Herrlich, A.; Ullrich, A. Signal characteristics of G-protein-transactivated EGF receptor. EMBO J. 1997, 16, 7032-7044.
73. Eguchi, S.; Numaguchi, K.; Iwasaki, H.; Matsumoto, T.; Yamakawa, T.; Utsunomiya, H.; Motley, E.D.; Kawakatsu, H.; Owada, K.M.; Hirata, Y.; Marumo, F.; Inagami, T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 1998, 273, 8890-8896.
74. Rajagopal, S.; Rajagopal, K.; Lefkowitz, R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 2010, 9, 373-386.
75. Luttrel, L.M.; Daaka, Y.; Lefkowitz, R.J. Regulation of tyrosine cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 1999, 11, 177-183.
76. Lefkowitz, R.J. Seven transmembrane receptors: something old, something new. Acta Physiol. (Oxf.) 2007, 190, 9-19.
77. Daub, H.; Weiss, F.U.; Wallasch, C.; Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379, 557-560.
78. Yamazaki, S.; Iwamoto, R.; Saeki, K.; Asakura, M.; Takashima, S.; Yamazaki, A.; Kimura, R.; Mizushima, H.; Moribe, H.; Higashiyama, S.; Endoh, M.; Kaneda, Y.; Takagi, S.; Itami, S.; Takeda, N.; Yamada, G.; Mekada, E. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J. Cell Biol. 2003, 163, 469-475.
79. Ohtsu, H.; Dempsey, P.J.; Satoru Eguchi, S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am. J. Physiol. Cell Physiol. 2006, 291, C1-C10.
80. Thelen, M.; Thelen, S. CXCR7, CXCR4 and CXCL12: An eccentric trio? J. Neuroimmunol. 2008, 198, 9-13
81. Singh, R.K.; Lokeshwar, B.L. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res. 2011, 71, 3268-3277.
82. Kasina, S.; Scherle, P.A.; Hall, C.L.; Macoska, J.A. ADAM-mediated amphiregulin shedding and EGFR transactivation. Cell Prolif. 2009, 42, 799-812.
83. Yan, Y.; Shirakabe, K.; Werb, Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 2002, 158, 221-226.
84. Cook, A.; Hippensteel, R.; Shimizu, S.; Nicolai, J.; Fatatis, A.; Meucci, O. Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons. J. Biol. Chem. 2010, 285, 10563-10571.
85. Pan, D.; Rubin, G.M. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 1997, 90, 271-280.
86. Moll, N.M.; Ransohoff, R.M. CXCL12 and CXCR4 in bone marrow physiology. Expert. Rev. Hematol. 2010, 3, 315-322.
87. McGrath, K.E.; Koniski, A.D.; Maltby, K.M.; McGann, J.K.; Palis, J. Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 1999, 213, 442-456.
88. Bleul, C.C.; Fuhlbrigge, R.C.; Casasnovas, J.M.; Aiuti, A.; Springer, T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 1996, 184, 1101-1109.
89. Vinante, F.; Rigo, A.; Scupoli, MT.; Pizzolo, G. CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. Blood 2002, 99, 52-60.
90. Montresor, A.; Bolomini-Vittori, M.; Simon, S.I.; Rigo, A.; Vinante, F.; Laudanna, C. Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines. Cancer Res. 2009, 69, 9281-9290.
91. Gupta, S.K.; Pillarisetti, K.; Lysko, P.G. Modulation of CXCR4 expression and SDF-1α functional activity during differentiation of human monocytes and macrophages. J. Leukoc. Biol. 1999, 66,135-143.
92. McCormick, P.J.; Segarra, M.; Gasperini, P.; Gulino, A.V.; Tosato, G. Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One 2009, 4, e8102.
93. Sánchez-Martín, L.; Estecha, A.; Samaniego, R.; Sánchez-Ramón, S.; Vega, M.Á.; Sánchez-Mateos, P. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 2011, 117, 88-97.
94. Müller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M.E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S.N.; Barrera, J.L.; Mohar, A.; Verástegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410, 50-56.
95. Kryczek, I.; Wei, S.; Keller, E.; Liu, R.; Zou, W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am. J. Physiol. Cell Physiol. 2007, 292, C987-C995.
96. Andreev, J.; Galisteo, M.L.; Kranenburg, O.; Logan, S.K.; Chiu, E.S.; Okigaki, M.; Cary, L.A.; Moolenaar, W.H.; Schlessinger, J. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated Protein (MAP) kinase signaling cascade. J. Biol. Chem. 2001, 276, 20130-20135.
97. Cabioglu, N.; Summy, J.; Miller, C.; Parikh, N.U.; Sahin, A.A.; Tuzlali, S.; Pumiglia, K.; Gallick, G.E.; Price, J.E. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Res. 2005, 65, 6493-6497.
98. Mahtouk, K.; Hose, D.; Rème, T.; De Vos, J.; Jourdan, M.; Moreaux, J.; Fiol, G.; Raab, M.; Jourdan, E.; Grau, V.; Moos, M.; Goldschmidt, H.; Baudard, M.; Rossi, J.F.; Cremer, F.W.; Klein, B. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 2005, 24, 3512-3524.
99. Lefkowitz, R.J.; Shenoy, S.K. Transduction of Receptor Signals by β-Arrestins. Science 2005, 308, 512-517.
100. Whalen, E.J.; Rajagopal, S.; Lefkowitz, R.J. Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol. Med. 2011, 17, 126-139.
101. Shenoy, S.K.; Lefkowitz, R.J. β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci. 2011, 32, 521-533.
102. Dealwis, C.; Fernandez, E.J.; Thompson, D.A.; Simon, R.J.; Siani, M.A.; Lolis, E. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 fusin coreceptor. Proc. Natl. Acad. Sci. USA 1998, 95, 6941-6946.
103. Fen, Z.; Dhadly, M.S.; Yoshizumi, M.; Hilkert, R.J.; Quertermous, T.; Eddy, R.L.; Shows, T.B.; Lee, M.E. Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor. Biochemistry 1993, 32, 7932-7938.
104. McCarthy, S.A.; Samuels, M.L.; Pritchard, C.A.; Abraham, J.A.; McMahon, M. Rapid induction of heparin-binding epidermal growth factor/ diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev. 1995, 9, 1953-1964.
105. Kerkhoff, E.; Rapp, U.R. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell Biol. 1997, 17, 2576-2586.
106. Hsu, H.; Xiong, J.; Goeddel, D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell 1995, 81, 495-504.
107. Schüle, R.; Umesono, K.; Mangelsdorf, D.J.; Bolado, J.; Pike, J.W.; Evans, R.M. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990, 61, 497-504.
108. Kwon, E.M.; Sakamoto, K.M. The molecular mechanism of action of granulocyte-macrophage colony-stimulating factor. J. Investig. Med. 1996, 44, 442-446.
109. Kaneto, H.; Miyagawa, J.; Kajimoto, Y.; Yamamoto, K.; Watada, H.; Umayahara, Y.; Hanafusa, T.; Matsuzawa, Y.; Yamasaki, Y.; Higashiyama, S.; Taniguchi, N. Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. A potential role of PDX-1 in transcriptional activation. J. Biol. Chem. 1997, 272, 29137-29143.
110. Kim, H.S.; Kim, M.S.; Hancock, A.L.; Harper, J.C.; Park, J.Y.; Poy, G.; Perantoni, A.O.; Cam, M.; Malik, K.; Lee, S.B. Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development. J. Biol. Chem. 2007, 282, 16278-16287.
111. Morrison, S.J.; Spradling, A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132, 598-611.
112. Wilson, A.; Trumpp, A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 2006, 6, 93-106.
113. Raaijmakers, M.H.G.P. Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system. Haematologica 2011, 96, 1041-1048.
114. Sugiyama, T.; Kohara, H.; Noda, M.; Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25, 977-988.
115. Adams, G.B.; Martin, R.P.; Alley, I.R.; Chabner, K.T.; Cohen, K.S.; Calvi, L.M.; Kronenberg, H.M.; Scadden, D.T. Therapeutic targeting of a stem cell niche. Nat. Biotechnol. 2007, 25, 238-243.
116. Kohara, H.; Omatsu, Y.; Sugiyama, T.; Noda, M.; Fujii, N.; Nagasawa, T. Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 2007, 110, 4153-4160.
117. Greenbaum, A.; Hsu, Y.M.; Day, R.B.; Schuettpelz, L.G.; Christopher, M.J.; Borgerding, J.N.; Nagasawa, T.; Link, D.C. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013, 495, 227-230.
118. Eminli, S.; Foudi, A.; Stadtfeld, M.; Maherali, N.; Ahfeldt, T.; Mostoslavsky, G.; Hock, H.; Hochedlinger, K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 2009, 41, 968-976.
119. Foudi, A.; Hochedlinger, K.; Van Buren, D.; Schindler, J.W.; Jaenisch, R.; Carey, V.; Hock, H. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat. Biotechnol. 2009, 27, 84-90.
120. Yamazaki, S.; Iwama, A.; Takayanagi, S.; Morita, Y.; Eto, K.; Ema, H.; Nakauchi, H. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J. 2006, 25, 3515-3523.
121. Santaguida, M.; Schepers, K.; King, B.; Sabnis, A.J.; Forsberg, EC.; Attema, J.L.; Braun, B.S.; Passegué, E. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 2009, 15, 341-352.
122. Yamazaki, S.; Iwama, A.; Takayanagi, S.; Eto, K.; Ema, H.; Nakauchi, H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 2009, 113, 1250-1256.
123. Arai, F.; Hirao, A.; Ohmura, M.; Sato, H.; Matsuoka, S.; Takubo, K.; Ito, K.; Koh, GY.; Suda, T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118, 149-161.
124. Fleming, HE.; Janzen, V.; Lo Celso, C.; Guo, J.; Leahy, KM.; Kronenberg, H.M.; Scadden, D.T. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008, 2, 274-283.
125. Davies, C.C.; Chakraborty, A.; Cipriani, F.; Haigh, K.; Haigh, J.J.; Behrens, A. Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation. Nat. Cell Biol. 2010, 12, 963-972.
126. Butler, J.M.; Nolan, D.J.; Vertes, E.L.; Varnum-Finney, B.; Kobayashi, H.; Hooper, A.T.; Seandel, M.; Shido, K.; White, I.A.; Kobayashi, M.; Witte, L.; May, C; Shawber, C; Kimura, Y.; Kitajewski, J.; Rosenwaks, Z.; Bernstein, ID.; Rafii, S. Endothelial cells are essential for the selfrenewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 2010, 6, 251-264.
127. Omatsu, Y.; Sugiyama, T.; Kohara, H.; Kondoh, G; Fujii, N.; Kohno, K.; Nagasawa, T. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33, 387-399.
128. Jenkinson, W.E.; Bacon, A.; White, A.J.; Anderson, G; Jenkinson, E.J. An epithelial progenitor pool regulates thymus growth. J. Immunol. 2008, 181, 6101-6108.
129. Petrie, H.T.; Zúñiga-PfluDcker, J.C. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu. Rev. Immunol. 2007, 25, 649-679.
130. Rode, I.; Boehm, T. Regenerative capacity of adult cortical thymic epithelial cells. Proc. Natl. Acad. Sci. USA 2012, 109, 3463-3468.
131. Zandstra, P.W.; Lauffenburger, D.A.; Eaves, C.J. A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis. Blood 2000, 96, 1215-1222.
132. Burger, J.A.; Kipps, T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107, 1761-1767.
133. Corcoran, K.E.; Trzaska, K.A.; Fernandes, H.; Bryan, M.; Taborga, M.; Srinivas, V.; Packman, K.; Patel, P.S.; Rameshwar, P. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One 2008, 3, e2563.
134. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
135. Hachet-Haas, M.; Balabanian, K.; Rohmer, F.; Pons, F.; Franchet, C.; Lecat, S.; Chow, K.Y.; Dagher, R.; Gizzi, P.; Didier, B.; Lagane, B.; Kellenberger, E.; Bonnet, D.; Baleux, F.; Haiech, J.; Parmentier, M.; Frossard, N.; Arenzana-Seisdedos, F.; Hibert, M.; Galzi, J.L. Small neutralizing molecules to inhibit actions of the chemokine CXCL12. J. Biol. Chem. 2008, 283, 23189-23199.
136. Sison, E.A.; Brown, P. The bone marrow microenvironment and leukemia: biology and therapeutic targeting. Expert. Rev. Hematol. 2011, 4, 271-283.
137. Tallman, M.S.; Gilliland, D.G.; Rowe, J.M. Drug therapy for acute myeloid leukemia. Blood 2005, 106, 1154-1163.
138. Appelbaum, F.R.; Rosenblum, D.; Arceci, R.J.; Carroll, W.L.; Breitfeld, P.P.; Forman, S.J.; Larson, R.A.; Lee, S.J.; Murphy, S.B.; O'Brien, S.; Radich, J.; Scher, N.S.; Smith, F.O.; Stone, R.M.; Tallman, M.S. End points to establish the efficacy of new agents in the treatment of acute leukemia. Blood 2007, 109, 1810-1816
139. Jabbour, E.; Kantarjian, H. Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management. Am. J. Hematol. 2012, 87, 1037-1045.
140. Gaidano, G.; Foà, R.; Dalla-Favera, R. Molecular pathogenesis of chronic lymphocytic leukemia. J. Clin. Invest. 2012, 122, 3432-3438.
141. Nanba, D.; Higashiyama, S. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor. Cytokine Growth Factor Rev. 2004, 15, 13-19.
142. Hatfield, K.J.; Reikvam, H.; Bruserud, Ø. The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia. Curr. Med. Chem. 2010, 17, 4448-4461.
143. Kim, H.Y.; Oh, Y.S.; Song, I.C.; Kim, S.W.; Lee, H.J.; Yun, H.J.; Kim, S.; Jo, D.Y. Endogenous stromal cell-derived factor-1 (CXCL12) supports autonomous growth of acute myeloid leukemia cells. Leuk. Res. 2013, doi:10.1016/j.leukres.2013.01.016.
144. Vinante, F.; Rigo, A.; Tecchio, C.; Morosato, L.; Nadali, G.; Ricetti, M.M.; Krampera, M.; Zanolin, E.; Locatelli, F.; Gallati, H.; Chilosi, M.; Pizzolo, G. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome. Br. J. Haematol. 1998, 102, 1025-1034.
145. Kornblau, S.M.; McCue, D.; Singh, N.; Chen, W.; Estrov, Z.; Coombes, K.R. Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia
146. Bonifacio, M.; Rigo, A.; Guardalben, E.; Bergamini, C.; Cavalieri, E.; Fato, R.; Pizzolo, G.; Suzuki, H.; Vinante, F. α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib. PLoS One 2012, 7, e46674.
147. Andhavarapu, S.; Roy, V. Immunomodulatory drugs in multiple myeloma. Expert Rev. Hematol. 2013, 6, 69-82.
148. Kumar, A.; Loughran, T.; Alsina, M.; Durie, B.G.; Djulbegovic, B. Management of multiple myeloma: a systematic review and critical appraisal of published studies. Lancet Oncol. 2003, 4, 293-304.
149. Reijmers, R.M.; Spaargaren, M.; Pals, S.T. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma. FEBS J. 2013, doi:10.1111/febs.12180.
150. Klein, B.; Tarte, K.; Jourdan, M.; Mathouk, K.; Moreaux, J.; Jourdan, E.; Legouffe, E.; De Vos, J.; Rossi, J.F. Survival and proliferation factors of normal and malignant plasma cells. Int. J. Hematol. 2003, 78, 106-113.
151. Blotta, S.; Jakubikova, J.; Calimeri, T.; Roccaro, A.M.; Amodio, N.; Azab, A.K.; Foresta, U.; Mitsiades, C.S.; Rossi, M.; Todoerti, K.; Molica, S.; Morabito, F.; Neri, A.; Tagliaferri, P.; Tassone, P.; Anderson, K.C.; Munshi, N.C. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma. Blood 2012, 120, 5002-5013.
152. Mirandola, L.; Apicella, L.; Colombo, M.; Yu, Y.; Berta, D.G.; Platonova, N.; Lazzari, E.; Lancellotti, M.; Bulfamante, G.; Cobos, E.; Chiriva-Internati, M.; Chiaramonte, R. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Leukemia 2013, doi:10.1038/leu.2013.27.
153. Badr, G.; Lefevre, E.A.; Mohany, M. Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis. PLoS One 2011, 6, e23741
154. Udi, J.; Schüler, J.; Wider, D.; Ihorst, G.; Catusse, J.; Waldschmidt, J.; Schnerch, D.; Follo, M.; Wäsch, R.; Engelhardt, M. Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization. Br. J. Haematol. 2013, 161, 104-116.
155. Mahtouk, K.; Cremer, F.W.; Rème, T.; Jourdan, M.; Baudard, M.; Moreaux, J.; Requirand, G.; Fiol, G.; De Vos, J.; Moos, M.; Quittet, P.; Goldschmidt, H.; Rossi, J.-F.; Hose, D.; Klein, B. Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma. Oncogene 2006, 25, 7180-7191.
156. Yoon, S.O.; Zhang, X.; Lee, I.Y.; Spencer, N.; Vo, P.; Choi, Y.S. CD9 is a novel marker for plasma cell precursors in human germinal centers. Biochem. Biophys. Res. Commun. 2013, 431, 41-46.